Innovative Diagnostic Technology Know Labs specializes in non-invasive medical diagnostics using proprietary RF dielectric spectroscopy, presenting a significant opportunity to target healthcare providers and medical device manufacturers seeking advanced, minimally invasive blood glucose monitoring solutions.

Growing Market Presence Having recently gone public and secured substantial funding of 20 million dollars, Know Labs demonstrates strong market confidence and expansion potential, making it a strategic partner for suppliers, investors, and collaborators in the health tech ecosystem.

Expanding Product Portfolio With the launch of its Generation 1 non-invasive glucose monitor and ongoing clinical studies, there’s a clear opportunity to engage with endocrinologists, diabetes care clinics, and healthcare institutions interested in cutting-edge disease management tools.

Technological Collaborations Partnerships with machine learning and AI firms like EdgeImpulse indicate a focus on enhancing algorithm accuracy, which opens doors for technology providers and software integrators to contribute to or integrate with Know Labs’ bio-RFID platform.

Strategic Growth Opportunities Targeting early adopters in diabetes care, wearable tech, and remote health monitoring sectors can accelerate sales, especially as Know Labs’ innovative, non-invasive solutions align with the increasing demand for patient-centric, real-time health monitoring devices.